René M. Vernhout - Concepedia

Author

René M. Vernhout

Also Known As

R M Vernhout, R Vernhout, R. M. Vernhout, R. Vernhout, R.M. Vernhout, Rene M. Vernhout, Rene Vernhout, René M Vernhout, René M. Vernhout, René Michel Vernhout

112

Publications

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus MC Cancer Institute University Medical Center Groningen Radboud University Nijmegen Erasmus University Rotterdam

About

René M. Vernhout is an author at Erasmus MC specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.5K
2	Health Sciences	5	5	458
3	Neurology	2	2	799
4	Immunology	1	1	16
5	Pathology	1	1	16

René M. Vernhout

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Management of Lung Nodules Detected by Volume CT Scanning Rob J. van Klaveren, Matthijs Oudkerk, Mathias Prokop, New England Journal of Medicine	2009	816
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial Walter Taal, Hendrika M. Oosterkamp, Annemiek Walenkamp, The Lancet Oncology Neuro-oncologyOncologySingle-agent BevacizumabMetronomic TherapyClinical Trials	2014	738
Nodule management protocol of the NELSON randomised lung cancer screening trial Dong Xu, Hester A. Gietema, Harry J. de Koning, Lung Cancer Cancer DetectionCancer ScreeningMedicineNodule Management ProtocolOncology	2006	342
Distributed learning on 20 000+ lung cancer patients – The Personal Health Train Timo M. Deist, Frank J. W. M. Dankers, Priyanka Ojha, Radiotherapy and Oncology	2020	155
Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules? Ernst T. Scholten, Pim A. de Jong, Bartjan de Hoop, European Respiratory Journal	2014	118
Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial Lale Erdem‐Eraslan, Martin J. van den Bent, Youri Hoogstrate, Cancer Research	2016	98
Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia Michiel Kroesen, Hendrik Thijmen Mulder, Jeanette M.L. van Holthe, Radiotherapy and Oncology Adaptive RadiotherapyLocal ControlCervical CancerRadiation TherapyMedicine	2019	84
Pemetrexed Maintenance Therapy in Patients with Malignant Pleural Mesothelioma Debby P.M. van den Bogaert, E.M. Pouw, Gerda van Wijhe, Journal of Thoracic Oncology Surgical OncologyMedicinePleural EffusionPleural DiseaseSurgery	2006	71
The Role of Conventional Bronchoscopy in the Workup of Suspicious CT Scan Screen-Detected Pulmonary Nodules Susan C. van ‘t Westeinde, Nanda Horeweg, René M. Vernhout, CHEST Journal Medical ImagingAdvanced Lung DiseaseMultiple Pulmonary NodulePulmonary MedicineConventional Bronchoscopy	2012	62
A randomized phase II study of bevacizumab versus bevacizumab plus lomustine versus lomustine single agent in recurrent glioblastoma: The Dutch BELOB study. Walter Taal, Hendrika M. Oosterkamp, Annemiek Walenkamp, Journal of Clinical Oncology High-grade GliomasRecurrent GlioblastomaGliomaNeuro-oncologyRadiation Medicine	2013	61

Page 1